| Abstrakt: |
Theranos today announced that nationally respected laboratory and medical experts have joined the company’s Scientific and Medical Advisory Board, whose membership now includes: Susan A. Evans, PhD, FACB, former president of the American Association For Clinical Chemistry (AACC); Bill Foege, MD, former Director of the U.S. Center for Disease Control and Prevention (CDC); Ann M. Gronowski, PhD, DABCC, Department of Pathology and Immunology and the Department of Obstetrics and Gynecology at the Washington University School of Medicine in St. Louis; David Helfet, MD, Hospital for Special Surgery and New York-Presbyterian Hospital, Weill Cornell Medicine; Larry J. Kricka, D. Phil, FRCPath, University of Pennsylvania; Jack Ladenson, PhD, DABCC, Washington University School of Medicine; Andy O. Miller, MD, Hospital for Special Surgery and New York-Presbyterian Hospital, Weill Cornell Medicine; and Steven Spitalnik, MD, Columbia University Medical Center (CUMC). [ABSTRACT FROM PUBLISHER] |
